Oxford Researchers Received Funding to create world’s first ovarian cancer prevention vaccine
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…
FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
On Mar. 6, 2018, the U.S. Food and Drug Administration authorized 23andMe’s Personal Genome Service Genetic Health Risk…
OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
BRCA2 gene mapped to chromosome 13q12-13
In 1995, The BRCA2 gene was mapped to chromosomal 13q. Just fifteen months later, Wooster et al. reported…
Scientists cloned the tumor suppressor genes BRCA1 and BRCA2
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
The first breast cancer gene was discovered
In 1994, Mary-Claire King, PhD, a University of Washington professor of genome sciences and medicine, discovered the “breast…